deltatrials

Myelodysplastic syndromes Trials in New York, United States

Conditions / Myelodysplastic syndromes / New York, United States

Myelodysplastic syndromes is a medical condition with active clinical research programs worldwide.

117 total trials for this combination

Showing top 10 of 117 trials

Trials

NCT ID Title Status Phase
NCT04904588 HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide ACTIVE_NOT_RECRUITING PHASE2
NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis ACTIVE_NOT_RECRUITING PHASE2
NCT00003793 Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma COMPLETED
NCT00028899 Monoclonal Antibody Plus Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndromes COMPLETED PHASE1
NCT03904134 Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) COMPLETED NA
NCT00109993 Campath-1H + FK506 and Methylprednisolone for GVHD COMPLETED PHASE2
NCT00006019 Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer COMPLETED PHASE2
NCT00014482 Music Therapy to Ease Pain and Emotional Distress in Patients With Hematologic Cancer Who Are Undergoing High-Dose Therapy and Stem Cell Transplantation COMPLETED NA
NCT00003593 Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome COMPLETED PHASE3
NCT03452774 SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry RECRUITING

Related Pages